Form DEFR14A - Revised definitive proxy soliciting materials:
SEC Accession No. 0001144204-15-053281
Filing Date
2015-09-01
Accepted
2015-09-01 17:08:55
Documents
6
Effectiveness Date
2015-09-01

Document Format Files

Seq Description Document Type Size
1 FORM DEFR14A v419604_defr14a.htm DEFR14A 268141
2 GRAPHIC tpg27d.jpg GRAPHIC 7487
3 GRAPHIC tpg27a.jpg GRAPHIC 1035
4 GRAPHIC tpg27b.jpg GRAPHIC 1118
5 GRAPHIC tpg27c.jpg GRAPHIC 1269
6 GRAPHIC tpg27f.jpg GRAPHIC 1442
  Complete submission text file 0001144204-15-053281.txt   287028
Mailing Address 855 N. WOLFE STREET SUITE 619 BALTIMORE MD 21205
Business Address 855 N. WOLFE STREET SUITE 619 BALTIMORE MD 21205 410-369-0365
CHAMPIONS ONCOLOGY, INC. (Filer) CIK: 0000771856 (see all company filings)

EIN.: 521401755 | State of Incorp.: DE | Fiscal Year End: 0430
Type: DEFR14A | Act: 34 | File No.: 001-11504 | Film No.: 151087959
SIC: 2836 Biological Products, (No Diagnostic Substances)